Yoshimoto, M.; Washiyama, K.; Ohnuki, K.; Doi, A.; Inokuchi, M.; Kojima, M.; Miller, B.W.; Yoshii, Y.; Inaki, A.; Fujii, H.
Long-Term Therapeutic Effects of 225Ac-DOTA-E[c(RGDfK)]2 Induced by Radiosensitization via G2/M Arrest in Pancreatic Ductal Adenocarcinoma. Pharmaceutics 2025, 17, 9.
https://doi.org/10.3390/pharmaceutics17010009
AMA Style
Yoshimoto M, Washiyama K, Ohnuki K, Doi A, Inokuchi M, Kojima M, Miller BW, Yoshii Y, Inaki A, Fujii H.
Long-Term Therapeutic Effects of 225Ac-DOTA-E[c(RGDfK)]2 Induced by Radiosensitization via G2/M Arrest in Pancreatic Ductal Adenocarcinoma. Pharmaceutics. 2025; 17(1):9.
https://doi.org/10.3390/pharmaceutics17010009
Chicago/Turabian Style
Yoshimoto, Mitsuyoshi, Kohshin Washiyama, Kazunobu Ohnuki, Ayano Doi, Miki Inokuchi, Motohiro Kojima, Brian W. Miller, Yukie Yoshii, Anri Inaki, and Hirofumi Fujii.
2025. "Long-Term Therapeutic Effects of 225Ac-DOTA-E[c(RGDfK)]2 Induced by Radiosensitization via G2/M Arrest in Pancreatic Ductal Adenocarcinoma" Pharmaceutics 17, no. 1: 9.
https://doi.org/10.3390/pharmaceutics17010009
APA Style
Yoshimoto, M., Washiyama, K., Ohnuki, K., Doi, A., Inokuchi, M., Kojima, M., Miller, B. W., Yoshii, Y., Inaki, A., & Fujii, H.
(2025). Long-Term Therapeutic Effects of 225Ac-DOTA-E[c(RGDfK)]2 Induced by Radiosensitization via G2/M Arrest in Pancreatic Ductal Adenocarcinoma. Pharmaceutics, 17(1), 9.
https://doi.org/10.3390/pharmaceutics17010009